N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study

Background: Multiple Sclerosis (MS) is an autoimmune disease marked by progressive neurocognitive injury. Treatment options affording neuroprotective effects remain largely experimental. The purpose of this proof of concept study was to explore the effects of N-acetyl-cysteine (NAC) on cerebral gluc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Neurol
Auteurs principaux: Monti, Daniel A., Zabrecky, George, Leist, Thomas P., Wintering, Nancy, Bazzan, Anthony J., Zhan, Tingting, Newberg, Andrew B.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Neurology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033492/
https://ncbi.nlm.nih.gov/pubmed/32117038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00088
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires